Earnings dates and session timing shown here are aggregated from third-party sources, are frequently estimated, and are subject to change or confirmation by the reporting company. Nothing on this site is financial advice.
Stevanato Group SpA (STVN) is a leading global provider of advanced drug delivery systems, specializing in innovative glass and polymer packaging solutions designed for injectable medications used by the pharmaceutical and biotechnology industries. With a steadfast focus on quality, sustainability, and the adoption of cutting-edge technologies, Stevanato is well-positioned to benefit from the burgeoning demand within the biopharmaceutical sector. The company’s dedication to enhancing the efficiency and reliability of drug administration makes it an attractive proposition for institutional investors looking for opportunities in healthcare innovation and sustainable growth.
Quotes and fundamental data are delayed and provided for informational purposes only — nothing on this page is financial advice. Figures are as reported by the company and its data providers and may be revised. Estimates reflect analyst consensus at the time of each report.
$21.03
| Quarter | EPS | Revenue | Price move | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Est | Adj | Result | GAAP | Est | Actual | Surprise | 1D Pre | On-Day | 1D Post | |
Q ended Jun 30, 2026 Reported Aug 4, 2026 | $0.15 | $0.16 | Beat +6.7% | — | $298.22M | $302M | +1.3% | 1D Pre+3.7% | On-Day-4.6% | 1D Post+2.3% |
Q ended Mar 31, 2026 Reported May 7, 2026 | $0.12 | $0.13 | Beat +8.3% | — | $268.72M | $273.57M | +1.8% | 1D Pre+4.3% | On-Day-5.1% | 1D Post+1.1% |
Q ended Dec 31, 2025 Reported Mar 4, 2026 | $0.16 | $0.20 | ||||||||
Dashed outlines show the analyst consensus estimate for periods where one was published. Hover or tap a bar for exact figures. Values as reported; not adjusted for splits after the report date.
| Beat +25.0% |
| — |
| $333.14M |
| $343.25M |
| +3.0% |
| 1D Pre-2.4% |
| On-Day+18.8% |
| 1D Post-9.1% |
Q ended Sep 30, 2025 Reported Nov 6, 2025 | $0.15 | $0.16 | Beat +6.7% | — | $290.61M | $303.17M | +4.3% | 1D Pre+1.1% | On-Day-2.4% | 1D Post-1.3% |